The primary objectives of the Animal Handling and Imaging Core are five-fold: 1) To purchase, create, or acquire mouse genetic models required for the program project and to maintain those to be used by two or more projects (""""""""CORE"""""""" mice) under a controlled breeding program. 2) To provide CORE mice to investigators for completion of project-specific experiments upon request. 3) To provide state-of-the-art facilities and technical support for, and expertise in, mammary-specific and general surgical procedures. 4) To serve as a center for coordination of tissue sharing among PPG investigators. 5) To provide imaging capabilities for evaluation of tumor development and metastasis in living mice. In addition, this Core will be responsible for all per diem cage costs related to the program project. Because space in the animal facility is finite, each project has been allocated a certain number of cages that can be maintained on average at any given time. Finally, the Animal Handling Core will provide a database of all mice generated by the project and documentation related to tissue samples, gene expression profiles, and histological evaluation. The data entry and database format will be based on our existing software for our extensive human tissue banks. Tissue sharing and animal space coordination among the Projects will result in specific cost savings, in addition to the enhanced effectiveness of shared expertise and facilities such as the imaging equipment. The Animal Handling and Imaging Core is required by all five Projects in the Program Project.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA030195-24
Application #
7275462
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
24
Fiscal Year
2006
Total Cost
$224,242
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Park, Jun Hyoung; Vithayathil, Sajna; Kumar, Santosh et al. (2016) Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer. Cell Rep 14:2154-2165
Pathiraja, Thushangi N; Nayak, Shweta R; Xi, Yuanxin et al. (2014) Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer. Sci Transl Med 6:229ra41
Zhang, Yi; Tseng, Chun-Chih; Tsai, Yuan-Li et al. (2013) Cancer cells resistant to therapy promote cell surface relocalization of GRP78 which complexes with PI3K and enhances PI(3,4,5)P3 production. PLoS One 8:e80071
Machado, Heather L; Kittrell, Frances S; Edwards, David et al. (2013) Separation by cell size enriches for mammary stem cell repopulation activity. Stem Cells Transl Med 2:199-203
Zhang, Xiaomei; Claerhout, Sofie; Prat, Aleix et al. (2013) A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models. Cancer Res 73:4885-97
Boone, David N; Lee, Adrian V (2012) Targeting the insulin-like growth factor receptor: developing biomarkers from gene expression profiling. Crit Rev Oncog 17:161-73
Casa, Angelo J; Potter, Adam S; Malik, Simeen et al. (2012) Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth. Breast Cancer Res Treat 132:61-73
Creighton, Chad J (2012) Molecular classification and drug response prediction in cancer. Curr Drug Targets 13:1488-94
Gutierrez, Carolina; Schiff, Rachel (2011) HER2: biology, detection, and clinical implications. Arch Pathol Lab Med 135:55-62
Wang, Yen-Chao; Morrison, Gladys; Gillihan, Ryan et al. (2011) Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers--role of estrogen receptor and HER2 reactivation. Breast Cancer Res 13:R121

Showing the most recent 10 out of 260 publications